Premium
Recalcitrant extragenital giant condyloma acuminatum: A need for combination therapy
Author(s) -
Lee ChawNing,
Hsu ChaoKai,
Lee Julia YuYun
Publication year - 2019
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.12867
Subject(s) - intertriginous , medicine , axilla , dermatology , imiquimod , cryotherapy , podophyllin , valaciclovir , surgery , condyloma acuminatum , pathology , human papillomavirus , virus , disease , cancer , virology , viral disease , breast cancer , herpesviridae
Giant condyloma acuminatum (GCA), also known as Buschke ‐Löwenstein tumor, is a huge, rapidly growing variant of condyloma found in the anogenital region. Extragenital GCA is rare and, in most cases, affecting the intertriginous area and treated by excision. We described a case of refractory extragenital GCA involving the large part of the left axilla area successfully treated with immunotherapy and podophyllotoxin. Considering the large size and the location, the lesions were not treated by wide excision because it might result in scar contracture with limitation of shoulder movement or axillary web syndrome. Our case illustrates that combination therapy of podophyllotoxin, imiquimod plus weekly cryotherapy may be an effective and less invasive option for treating GCA of the axilla with good cosmetic and functional outcomes.